CollabRx
| Company type | Private |
|---|---|
| Industry | Health informatics, Software-as-a-service |
| Founded | 2008 |
| Founder | Jeff Shrager, Jay Martin Tenenbaum, Raphael Lehrer |
| Fate | Acquired by Tegal Corporation in July 2012; combined with Medytox Solutions in October 2015 |
Key people | Jeff Shrager, Jay Martin Tenenbaum, Raphael Lehrer |
| Products | Cloud-hosted expert systems for clinical treatment decisions in molecular diseases |
CollabRx, Inc. specialized in delivering cloud-hosted expert systems designed to assist in choosing clinical treatments for molecular illnesses such as cancer. The core innovation involved continuously updated molecular disease models that underpinned these decision-support systems. One of the major business objectives was to derive clinically actionable therapeutic strategies from extensive biological datasets. The knowledgebases that supported these models were regularly refreshed by a broad consortium of experts from academic and healthcare institutions.
The expert systems were accessible via software-as-a-service agreements. The main clientele comprised DNA testing laboratories focused on converting patient-specific genetic information into customized clinical treatment plans for molecular diseases.
History
Established in 2008, CollabRx was founded by computer scientist Jeff Shrager, Silicon Valley internet innovator Jay Martin Tenenbaum, and mathematician Raphael Lehrer.
In July 2012, CollabRx was acquired by Tegal Corporation, enhancing its portfolio in genomics-driven medicine through enriched interpretive content and data analysis capabilities.
By October 2015, CollabRx combined operations with Medytox Solutions, further embedding its molecular disease knowledge into comprehensive healthcare offerings.